DaVita Inc.
Market Data Current As Of: September 12, 2026
Related Competitor Intelligence
Compare market positioning with top industry peers
Explore DaVita
Core profile pages, annual revenue records, and related research hubs for this company.
DaVita Inc.
Compare market positioning with top industry peers
Explore DaVita
Core profile pages, annual revenue records, and related research hubs for this company.
Business Model Analysis
Annual Revenue: $13.643B
DaVita generates revenue primarily through Kidney care and dialysis services, reporting roughly $13.643B in annual revenue.
Core Growth Engine: DaVita grows by improving clinic utilization, expanding integrated kidney care, managing payer relationships, investing in home dialysis, and selectively building or acquiring centers....
DaVita operates primarily as a dominant, specialized kidney care provider, heavily centered on safely delivering life-sustaining dialysis services for ill patients specifically suffering from End-Stage Kidney Disease (ESKD). DaVita's recurring, stable business model is built on providing these essential, life-sustaining medical treatments to a captive, chronic patient population that typically requires intense, multi-hour dialysis sessions at least three times a week, every single week of the year. The vast, overwhelming majority of the company's total corporate revenue is directly derived from core outpatient hemodialysis and peritoneal dialysis patient services. The fundamental, underlying economics of DaVita's business model are entirely driven by its complex payer mix. While government-funded programs like federal Medicare and state Medicaid provide the bulk of the total patient treatment volume (often exceeding 89% of all patients), these vital public programs typically reimburse DaVita at significantly lower, heavily regulated rates. In stark contrast, private commercial insurance plans, which represent a smaller overall share of total patient volume, are exponentially more profitable for the company, as they reimburse treatments at substantially higher market rates. Therefore, actively managing this delicate payer mix balance, alongside expanding into lucrative, risk-based Integrated Kidney Care (IKC) arrangements, remains the most critical driver of the company’s long-term financial performance and operational viability.
DaVita grows by improving clinic utilization, expanding integrated kidney care, managing payer relationships, investing in home dialysis, and selectively building or acquiring centers.
DaVita Inc.'s business model is anchored by its core commercial operations: DaVita operates primarily as a dominant, specialized kidney care provider, heavily centered on safely delivering life-sustaining dialysis services for ill patients specifically suffering from End-Stage Kidney Disease (ESKD).
By integrating workflow automation into product delivery, DaVita Inc. deepens customer engagement and strengthens recurring cash flows in Kidney care and dialysis services.
In 2026, DaVita Inc. continues refining operational efficiency to lower customer acquisition costs while scaling gross margins across key markets.